(A) Left, Schematic of a parasagittal section of the cerebellum showing injection site for anterograde tracing from mCbN. Middle, Confocal image of the mCbN after injection of AAV-hSyn-ChR2-eYFP …
(A) Schematic of the approximate rostro-caudal level of the highest density of mCbN labeled fibers in the vlPAG. Box denotes boundaries of image in panel (B). Abbreviations: SuG: superficial grey …
(A) Action potentials in a Chx10-ChR2 expressing neuron in the vlPAG during a train (100 stimuli, 50 Hz, 10 ms) of light. (B) Spike raster of 10 consecutive sweeps during stimulation of the cell in …
(A) Spontaneous action potentials from a Chx10 neuron. (B) Population data for spontaneous firing rates of Chx10 neurons. (C) Single spontaneous action potential of a Chx10 neuron. (D) Phase-plane …
(A) Spontaneous action potentials in a GAD2+ (green) and a Chx10 (black) neuron. (B) Population data for spontaneous firing rates of GAD2 and Chx10 neurons. Open symbols, individual cells, solid …
(A) Spontaneous action potentials recorded from mCbN neurons from males (blue) and females (red). (B) Population data of spontaneous firing rates separated by sex. Open symbols, individual cells, sol…
(A, B) Spontaneous action potentials of iCbN (left) and mCbN (right) neurons from females (A) and males (B). (C) Mean and SEM of firing rates of iCbN and mCbN neurons, pooled for both sexes. Asterisk…
(A) EPSCs evoked in a Chx10 cell by optogenetic stimulation of mCbN afferents. (B) Percentage of tested cells in which responses could be elicited (grey bars) and population data for EPSC amplitudes …
(A) Distribution of TH neurons in the vlPAG. (B) Optogenetically evoked EPSCs in a TH neuron. (C) Population data for the first EPSC (left) and PPR (right) evoked as in B. Open symbols, individual …
(A) Top, protocol for stimulating electrically (upper line) and optogenetically (lower line). Bottom, IPSCs without (black) and with (color) mCbN stimulation. (B) Population data for percent change …
(A) Left, Electrically evoked IPSCs before (black) and during (color) bath application of the D2-receptor agonist quinpirole (25 μM). Right, As at left, but with D1 receptors activated by dopamine …
(A) Top, protocol for stimulating electrically (upper line) and optogenetically (lower line). Bottom, IPSCs without (black) and with (color) mCbN stimulation in the presence of sulpiride. (B) …
Responses evoked by optogenetic activation of Chx10 neurons in the vlPAG (10 ms, 50 Hz, 5 s) is indicated by ‘Light On.’.
Parameter | All Cells (n=26) | Males (n=15) | Females (n=11) | p value |
---|---|---|---|---|
Intrinsic Properties | ||||
Membrane Resistance (MΩ) | 584.1 ± 47.3 | 648.6 ± 62.2 | 496.0 ± 66.9 | 0.1 |
Capacitance (pF) | 24.2 ± 1.3 | 23.4 ± 1.5 | 25.2 ± 2.5 | 0.6 |
Interspike Vm (mV)* | -48.7 ± 1.0 | -50.6 ± 1.0 | -45.9 ± 1.6 | 0.02 |
Action Potential Properties | ||||
Spontaneous Rate (spikes/s) | 5.8 ± 1.2 | 4.5 ± 1.4 | 7.6 ± 1.9 | 0.2 |
Maximum dV/dt (V/s) | 155.2 ± 11.4 | 153.9 ± 13.5 | 157.0 ± 20.5 | 0.9 |
Estimated Peak INa (nA) | 4.0 ± 0.5 | 3.7 ± 0.5 | 4.3 ± 0.9 | 0.6 |
Minimum dV/dt (V/s) | -63.9 ± 5.0 | -55.1 ± 4.0 | -76.0 ± 9.5 | 0.06 |
Estimated Peak IK (nA) | 1.6 ± 0.2 | 1.3 ± 0.1 | -2.1 ± 0.4 | 0.06 |
Halfwidth (ms) | 1.0 ± 0.1 | 1.1 ± 0.07 | 0.9 ± 0.1 | 0.06 |
Amplitude (mV) | 55.9 ± 2.2 | 57.3 ± 2.7 | 54.1 ± 3.5 | 0.5 |
Threshold (mV) | -31.6 ± 0.8 | -32.5 ± 1.0 | -30.4 ± 1.4 | 0.2 |
Rheobase at -70 mV (pA) | 9.8 ± 0.8 | 9.6 ± 1.0 | 10.0 ± 1.4 | 0.8 |
* indicates significant difference between males and females.
Parameter | All Cells (n=28) | Males (n=15) | Females (n=13) | p value |
---|---|---|---|---|
Intrinsic Properties | ||||
Membrane Resistance (MΩ) | 77.5 ± 12.8 | 62.2 ± 8.1 | 95.5 ± 17.0 | 0.08 |
Capacitance (pF) | 68.6 ± 5.5 | 79.7 ± 12.6 | 55.2 ± 5.8 | 0.09 |
Action Potential Properties | ||||
Spontaneous Rate (spike/s)* | 122.8 ± 6.6 | 137.4 ± 8.8 | 105.9 ± 9.0 | 0.01 |
Maximum dV/dt (V/s) | 294.3 ± 19.0 | 270.6 ± 16.6 | 321.8 ± 34.6 | 0.2 |
Estimated Peak INa (nA) | 19.4 ± 2.0 | 20.8 ± 2.9 | 17.9 ± 2.8 | 0.5 |
Minimum dV/dt (V/s) | -270.7 ± 20.1 | -242.1 ± 19.4 | -303.4 ± 38.4 | 0.2 |
Estimated Peak IK (nA) | 17.8 ± 1.8 | 18.4 ± 2.4 | 17.2 ± 3.0 | 0.7 |
Halfwidth (ms) | 0.27 ± 0.02 | 0.27 ± 0.2 | 0.27 ± 0.4 | 0.9 |
Ampliutde (mV) | 53.2 ± 1.5 | 51.7 ± 1.7 | 54.9 ± 2.8 | 0.3 |
Threshold (mV) | -42.3 ± 0.7 | -41.7 ± 1.0 | -43.0 ± 1.1 | 0.4 |
* indicates significant difference between males and females.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional Information |
---|---|---|---|---|
Strain, strain background Mus musculus | Chx10-cre | Obtained from Jessell Laboratory (Crone et al., 2008) | ||
Strain, strain background Mus musculus | tdTomato (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J) | Jackson Laboratories | Stock: 007914 | |
Strain, strain background Mus musculus | ChR2-EYFP (B6.Cg-Gt(ROSA)26 Sortm32(CAG-COP4*H134R/EYFP)Hze/J) | Jackson Laboratories | Stock: 024109 | |
Strain, strain background Mus musculus | GAD2-cre (B6N.Cg-Gad2tm2(cre)Zjh/J) | Jackson Laboratories | Stock:019022 | |
Strain, strain background Mus musculus | TH-cre (B6.Cg-7630403G23 RikTg(Th-cre)1Tmd/J) | Jackson Laboratories | Stock: 008601 | |
Strain, strain background Mus musculus | L7-Cre (B6.Cg-Tg(Pcp2-cre)3555Jdhu/J) | Jackson Laboratories | Stock: 010536 | |
Recombinant DNA reagent | AAV2-EF1α-DIO-hChR2(H134R)-eYFP | UNC Viral Vector Core | ||
Recombinant DNA reagent | AAV2-hSyn-hChR2 (H134R)-eYFP-WPRE-PA | UNC Viral Vector Core | ||
Recombinant DNA reagent | AAVdj-hSyn-hChR2(E123A)-eYFP-WPRE | Stanford Viral Vector Core | ||
Recombinant DNA reagent | AAV2-EF1α-DIO-eYFP | UNC Viral Vector Core | ||
Chemical compound, drug | Cholera Toxin Subunit B (Recombinant), Alexa Fluor 488 Conjugate | ThermoFisher Scientific | Cat. No. C22841 | |
Chemical compound, drug | Lumafluor red retrobeads | LumaFluor | Red Retrobeads IX | |
Chemical compound, drug | DNQX | Tocris | Cat. No. 0189 | |
Chemical compound, drug | CPP | Tocris | Cat. No. 0247 | |
Chemical compound, drug | CPCCOEt | Tocris | Cat. No. 1028 | |
Chemical compound, drug | Sulpiride | Tocris | Cat. No. 0894 | |
Chemical compound, drug | SCH 23390 | Tocris | Cat. No. 0925 | |
Chemical compound, drug | Prazosin | Tocris | Cat. No. 0623 | |
Chemical compound, drug | Sotalol | Tocris | Cat. No. 0952 | |
Chemical compound, drug | Quinpirole | Tocris | Cat. No. 1061 | |
Chemical compound, drug | Dopamine | Tocris | Cat. No. 3548 | |
Chemical compound, drug | Isoproterenol | Tocris | Cat. No 17.47 | |
Software, algorithm | FreezeFrame | Actimetrics (www.actimetrics.com) |